Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 2/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | RBP4 | P02753 | 1/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5084668 | 1.00 | CYP17A1 (0.37) | CYP17A1CYP19A1RBP4DGAT1ALDH1A1 | |
| SCHEMBL5080907 | 0.93 | CYP17A1 (0.41) | CYP17A1CYP19A1MEN1MAPK1KMT2A | |
| SCHEMBL5568146 | 0.86 | ALDH1A1 (0.44) | CYP17A1CYP19A1RBP4ALDH1A1MEN1 | |
| SCHEMBL30798137 | 0.85 | CYP17A1 (0.46) | CYP17A1CYP19A1ALDH1A1MEN1MAPK1 | |
| SCHEMBL1732799 | 0.84 | CYP17A1 (0.36) | CYP17A1CYP19A1ALDH1A1MEN1MAPK1 | |
| SCHEMBL5084562 | 0.83 | GRM1 (0.33) | DGAT1 | |
| SCHEMBL5082295 | 0.83 | GRM1 (0.33) | DGAT1 | |
| SCHEMBL16933170 | 0.83 | GRM1 (0.33) | DGAT1 | |
| SCHEMBL5081750 | 0.83 | GRM1 (0.33) | DGAT1 | |
| SCHEMBL1733193 | 0.83 | DGAT1 (0.31) | DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160252818-A9 | PRODUCTION METHOD OF SEMICONDUCTOR ELEMENT, AND ION IMPLANTATION METHOD | JSR CORPORATION (JP) | 2016-09-01 | — | — | US | disclosed |
| US-20160252818-A9 | PRODUCTION METHOD OF SEMICONDUCTOR ELEMENT, AND ION IMPLANTATION METHOD | JSR CORPORATION (JP) | 2016-09-01 | — | — | US | disclosed |
| US-20150355550-A1 | PRODUCTION METHOD OF SEMICONDUCTOR ELEMENT, AND ION IMPLANTATION METHOD | JSR CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| US-20150355550-A1 | PRODUCTION METHOD OF SEMICONDUCTOR ELEMENT, AND ION IMPLANTATION METHOD | JSR CORPORATION (JP) | 2015-12-10 | — | — | US | disclosed |
| WO-2014171429-A1 | PRODUCTION METHOD FOR SEMICONDUCTOR ELEMENT AND ION IMPLANTATION METHOD | JSR株式会社 (JP) | 2014-10-23 | — | — | WO | disclosed |
| EP-1462471-B1 | Dielectric films and materials therefor | DAICEL CHEM (JP) | 2008-07-30 | — | — | EP | disclosed |
| US-20070078256-A1 | Prepolymers, prepolymer compositions, high-molecular-weight polymers with pore structure, and dielectric films | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-05 | — | — | US | disclosed |
| US-7186454-B2 | Dielectric films and materials therefor | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-03-06 | — | — | US | disclosed |
| US-20070032556-A1 | Aromatic polyamine derivative | DAICEL CHEMICAL INSUSTRIES, LTD. (JP) | 2007-02-08 | — | — | US | disclosed |
| US-20060264667-A1 | Adamantanetricarboxylic acid derivatives | NAGANO SHINYA | 2006-11-23 | — | — | US | disclosed |
| US-7102027-B2 | Adamantanetricarboxylic acid derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2006-09-05 | — | — | US | disclosed |
| EP-1683822-A1 | PREPOLYMER, PREPOLYMER COMPOSITION, HIGH MOLECULAR WEIGHT POLYMER HAVING STRUCTURE CONTAINING HOLE AND ELECTRICALLY INSULATING FILM | Daicel Chemical Industries, Ltd. (JP) | 2006-07-26 | — | — | EP | disclosed |
| EP-1681284-A1 | AROMATIC POLYAMINE DERIVATIVE | Daicel Chemical Industries, Ltd. (JP) | 2006-07-19 | — | — | EP | disclosed |
| US-20040242923-A1 | Adamantanetricarboxylic acid derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-12-02 | — | — | US | disclosed |
| EP-1462471-A1 | Dielectric films and materials thereof | Daicel Chemical Industries, Ltd. (JP) | 2004-09-29 | — | — | EP | disclosed |
| US-20040175858-A1 | Dielectric films and materials therefor | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242923-A1 | Adamantanetricarboxylic acid derivatives | HCAR1, CA1, ALDH7A1 | CYP17A1 581/4885CYP19A1 915/4885RBP4 2746/4885 |
| US-20070032556-A1 | Aromatic polyamine derivative | SRM, PRMT1, KDM8 | CYP17A1 1864/4885CYP19A1 1985/4885RBP4 1646/4885 |
| US-20060264667-A1 | Adamantanetricarboxylic acid derivatives | CA1, HCAR1, ALDH7A1 | CYP17A1 589/4885CYP19A1 665/4885RBP4 3420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.